These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8431763)

  • 21. Truncated tau protein as a new marker for Alzheimer's disease.
    Novák M
    Acta Virol; 1994 Jun; 38(3):173-89. PubMed ID: 7817900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective.
    Iqbal K; Grundke-Iqbal I
    J Alzheimers Dis; 2006; 9(3 Suppl):219-42. PubMed ID: 16914861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.
    Bancher C; Brunner C; Lassmann H; Budka H; Jellinger K; Wiche G; Seitelberger F; Grundke-Iqbal I; Iqbal K; Wisniewski HM
    Brain Res; 1989 Jan; 477(1-2):90-9. PubMed ID: 2495152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins.
    Layfield R; Fergusson J; Aitken A; Lowe J; Landon M; Mayer RJ
    Neurosci Lett; 1996 May; 209(1):57-60. PubMed ID: 8734909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
    Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.
    Sergeant N; David JP; Lefranc D; Vermersch P; Wattez A; Delacourte A
    FEBS Lett; 1997 Aug; 412(3):578-82. PubMed ID: 9276470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles.
    Colle MA; Duyckaerts C; Laquerrière A; Pradier L; Czech C; Checler F; Hauw JJ
    Neuropathol Appl Neurobiol; 2000 Apr; 26(2):117-23. PubMed ID: 10840274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosylation of microtubule-associated protein tau in Alzheimer's disease brain.
    Takahashi M; Tsujioka Y; Yamada T; Tsuboi Y; Okada H; Yamamoto T; Liposits Z
    Acta Neuropathol; 1999 Jun; 97(6):635-41. PubMed ID: 10378383
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Pluta R; Czuczwar SJ
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A tau-related protein of 130 kDa is present in Alzheimer brain.
    Gache Y; Guilleminot J; Ricolfi F; Theiss G; Nunez J
    J Neurochem; 1992 Jun; 58(6):2005-10. PubMed ID: 1374115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Trends Neurosci; 1993 Nov; 16(11):460-5. PubMed ID: 7507619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease.
    Nakano H; Kobayashi K; Sugimori K; Shimazaki M; Miyazu K; Hayashi M; Furuta H
    Dement Geriatr Cogn Disord; 2004; 17(3):122-31. PubMed ID: 14739532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease.
    Crowther RA; Olesen OF; Jakes R; Goedert M
    FEBS Lett; 1992 Sep; 309(2):199-202. PubMed ID: 1505683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease.
    Masliah E; Mallory M; Alford M; Hansen LA; Saitoh T
    Lab Invest; 1993 Nov; 69(5):562-9. PubMed ID: 8246448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.